Le polynucléaire basophile: du contrôle de l'immunité à celui des leucémies

M Arock - Annales Pharmaceutiques Françaises, 2022 - Elsevier
Résumé Les polynucléaires basophiles, décrits pour la première fois par Paul Ehlrich en
1879, sont des cellules circulantes rares, représentant environ 0, 01 à 0, 3% des leucocytes …

Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders

H Agis, MT Krauth, A Böhm, I Mosberger… - American journal of …, 2006 - academic.oup.com
In myeloproliferative disorders (MPDs), basophils typically increase in number in the bone
marrow (BM) and blood. In chronic myeloid leukemia (CML), basophilia is a diagnostic and …

High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis

M Lucijanic, A Livun, T Stoos-Veic, V Pejsa, O Jaksic… - …, 2018 - Taylor & Francis
Objectives: To investigate the clinical and prognostic significance of absolute basophil count
(ABC) in patients with primary myelofibrosis (PMF). Methods: We retrospectively investigated …

Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody …

H Agis, MT Krauth, I Mosberger, L Müllauer… - Journal of clinical …, 2006 - jcp.bmj.com
Background: Basophils are highly specialised granulocytes that express a unique profile of
antigens and increase in myeloproliferative disorders (MPD). In chronic myeloid leukaemia …

A comparative study of Hasford score and Sokal index in prognostication of the novo chronic myeloid leukemia patients and a search for new prognostic markers

SK Sinha, S Sinha, PK Mandal… - Indian Journal of …, 2013 - journals.lww.com
Aims and Objectives: Our study's objective is to compare Hasford score with Sokal index for
the prognostication of de novo CML patients on therapy and find out new prognostic …

[PDF][PDF] Chronic myeloid leukemia: a disease of youth in Brazil

MGV de Campos, A de Moraes Arantes… - Leukemia …, 2010 - academia.edu
Chronic myeloid leukemia (CML) is usually an insidious disease and the median age at
diagnosis is stated in Hematology text books to be around 50 years. In the past, patients …

Evaluation of visual evoked potential in chronic myeloid leukemias

A Agrawal, S Aggarwal, R Singh… - Oman Journal of …, 2023 - journals.lww.com
BACKGROUND: Visual complaint is not very uncommon in chronic myeloid leukemia (CML)
patients. Our study aims to evaluate the visual pathway using visual evoked potential (VEP) …

Development of a predictive population survival model according to the cytogenetic response rate for patients with chronic myeloid leukemia in the chronic phase

RJ Schrover, MA Adena… - Leukemia & …, 2006 - Taylor & Francis
This study sets out to investigate whether the proportion of patients with chronic myeloid
leukemia (CML) in the chronic phase who achieve a major cytogenetic response (MCR) can …

Basophil progenitor marker histamine and its relation to the treatment response in Egyptian chronic myeloid leukemia patients

AM El-Ghammaz, GM Hamed… - The Egyptian Journal …, 2015 - journals.lww.com
Results Histamine levels were upregulated in CML patients at diagnosis compared with the
healthy control group and correlated with the total leukocytic count, the absolute peripheral …

Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate

ND Eyüpoğlu, OE Çınar, S Aksu, Y Büyükaşık… - Acta Medica, 2022 - actamedica.org
Objective: Chronic myeloid leukemia (CML) prognostication at the time of diagnosis is
critical to determine the intensity of initial treatment. Event-free survival (EFS) has become a …